Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROMIDEPSIN: Safety Overview

Metric ROFLUMILAST ROMIDEPSIN
Total FAERS Reports 2,700 1,282
Deaths Reported 645 343
Death Rate 23.9% 26.8%
Hospitalizations 625 458
Average Patient Age 68.8 yrs 64.7 yrs
% Female Patients 56.3% 46.5%
FDA Approval Date Apr 17, 2023 Mar 13, 2020
Manufacturer Aurobindo Pharma Limited Fresenius Kabi USA, LLC
Route ORAL N/A
Marketing Status Prescription Prescription